Release Date: 09/07/18 11:23 Summary: Revised Securities Trading Policy Price Sensitive: No Download Document 339.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%